Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

May 5, 2025 — Chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world's deadliest pathogen. This labeling could lead to simpler ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Genetic modification of mycobacteria is a difficult process. In this innovation, van Kessel and colleagues describe a new system of recombineering that facilitates the production of mutants in ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

Two lipoglycans, lipomannan (LM) and lipoarabinomannan (LAM), play various, albeit incompletely defined, roles in the interactions of mycobacteria with the host. Growing evidence points to the ...